Lithium was introduced as a therapy firstly in order to augment the existing antipsychotic therapy, and secondly as potential protection against hematopoiesis in order to increase the number of thrombocytes after idiopathic thrombocytopenia had been diagnosed.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:There are numerous data on the effects of lithium on the hematopoietic system, especially in aplastic anemia and thrombocytopenia.
📊
Key Findings & Data:This case shows a dual effect of therapy with lithium carbonate in a 49-year-old patient with schizophrenic psychosis and idiopathic thrombocytopenia.
💡
Conclusion & Impact:Lithium was introduced as a therapy firstly in order to augment the existing antipsychotic therapy, and secondly as potential protection against hematopoiesis in order to increase the number of thrombocytes after idiopathic thrombocytopenia had been diagnosed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
There are numerous data on the effects of lithium on the hematopoietic system, especially in aplastic anemia and thrombocytopenia. This case shows a dual effect of therapy with lithium carbonate in a 49-year-old patient with schizophrenic psychosis and idiopathic thrombocytopenia. Lithium was introduced as a therapy firstly in order to augment the existing antipsychotic therapy, and secondly as potential protection against hematopoiesis in order to increase the number of thrombocytes after idiopathic thrombocytopenia had been diagnosed.
🔖
Cite This Article
SAKIC, B. O., DADASOVIC, J. D. (2022). Idiopathic thrombocytopenia side-effect of lithium in a patient with schizophrenia. Klinik Psikofarmakoloji Bülteni, Cilt: 23 - Sayı: 2, 180–182. https://ajindex.com/articles/652936
Garver DL, Hirschowitz J, Fleischmann R, Djuric PE. Lithium response and psychoses: a double – blind, placebo – controlled study. Psychiatry Res 1984;12(1):57-68
Johns CA, Thompson JW. Adjunctive Treatments in Schizophrenia: Pharmacotherapies and Electroconvulsive Therapy. Schizophr Bull 1995;21(4):607-19
Hager ED, Dziambor H, Hohmann D, Winkler P, Strama H. Effects of lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy. Biol Trace Elem Res 2001;83(2):139-48
Alexander PE, van Kammen DP, Bunney WE Jr. Antipsychotic effects of lithium in schizophrenia. Am J Psychiatry 1979;136(3):283-7
Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M, et al. Clozapine-Induced Neutropenia in Children: Management with lithium carbonate. J Child Adolesc Psychopharmacol 2003;13(3):401-4
Lerner Y, Mintzer Y, Schestatzky M. Lithium combined with haloperidol in schizophrenic patients. Br J Psychiatry 1988;153:359-62
Petrini M, Azzara A. Lithium in the treatment of neutropenia. Curr Opin Hematol 2012;19(1):52-7
Tevfik K, Akif T, Abdullah G, Esra S, Ismail O, Dilek Y, et al. The review of hematologic and other biochemical parameters in lithium monotherapy patients. Journal of Mood Disorders 2012;2(3):109-14
Focosi D, Azzara A, Kast RE, Carulli G, Petrini M. Lithium and Hematology: established and proposed uses, J Leukoc Biol 2009;85(1):20-8
Collins PJ, Larkin EP, Shubsachs AP. Lithium carbonate in chronic schizophrenia--a brief trial of lithium carbonate added to neuroleptics for treatment of resistant schizophrenic patients. Acta Psychiatr Scand 1991;84(2):150-4
Leucht S, Kissling W, McGrath J. Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry 2004;65(2):177- 86.